Statistics for Enliven Therapeutics, - Common Stock (id:7856 ELVN)
Valuation metrics
Market cap
1.22B
Enterprise value
-290,632,160.00
Trailing P/E (ttm)
-12.21
Forward P/E
-10.51
PEG ratio
-10.51
Price/Sales (ttm)
Price/Book (mrq)
0.00
Enterprise Value/Revenue
Enterprise Value/EBITDA
2.94
Overview
Shares outstanding
48.86M
Float
25.52K
Shares short
6.91M
% Held by insiders
0.06%
% Held by institutions
0.99%
Average volume (10 days)
258.18K
Average volume (90 days)
Price summary
52-Week low
9.80
52-Week high
30.03
52-Week change
55.18%
Beta
50-Day moving average
26.28
200-Day moving average
21.87
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-21.37%
Return on equity
-30.98%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-98,775,000.00
Net income to common (ttm)
-85,214,000.00
Diluted EPS (ttm)
-1.93
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
291.83M
Total cash per share (mrq)
6.05K
Total debt (mrq)
0.00
Total Debt/Equity (mrq)
0.00
Current ratio (mrq)
1.74K%
Book value per share (mrq)
5.98K
Cash flow
Cash flow statement
-60,627,000.00
Levered free cash flow (LFCF)
-71,584,000.00